avelumabutomilumabPF-04518600anti-OX40anti-4-1BBOX40The University of Texas MD Anderson Cancer CenterPfizersolid tumorscolorectal and pancreatic cancers
…pre-treatment longitudinal changes following the combination of avelumab with utomilumab (a 4-1BB agonist) (arm A), PF-04518600 (an OX40…